Peptidyl-prolyl cis/trans-Isomerase A1 (Pin1) Is a Target for Modification by Lipid Electrophiles

被引:27
|
作者
Aluise, Christopher D. [1 ,2 ,3 ]
Rose, Kristie [4 ]
Boiani, Mariana [1 ,2 ,3 ]
Reyzer, Michelle L. [1 ,2 ,3 ]
Manna, Joseph D. [1 ,2 ,3 ]
Tallman, Keri [2 ]
Porter, Ned A. [2 ]
Marnett, Lawrence J. [1 ,2 ,3 ]
机构
[1] Vanderbilt Univ, Ctr Mol Toxicol, Vanderbilt Inst Chem Biol, Sch Med,Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Ctr Mol Toxicol, Vanderbilt Inst Chem Biol, Sch Med,Dept Chem, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Ctr Mol Toxicol, Vanderbilt Inst Chem Biol, Sch Med,Dept Pharmacol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA
关键词
MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; PEROXIDATION PRODUCT; SECONDARY STRUCTURE; BOND CONFORMATION; OXIDATIVE STRESS; ISOMERIZATION; PROTEINS; BRAIN; IDENTIFICATION;
D O I
10.1021/tx300449g
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Oxidation of membrane phospholipids is associated with inflammation, neurodegenerative disease, and cancer. Oxyradical damage to phospholipids results in the production of reactive aldehydes that adduct proteins and modulate their function. 4-Hydroxynonenal (HNE), a common product of oxidative damage to lipids, adducts proteins at exposed Cys, His, or Lys residues. Here, we demonstrate that peptidyl-prolyl cis/trans-isomerase A1 (Pin1), an enzyme that catalyzes the conversion of the peptide bond of pSer/pThr-Pro moieties in signaling proteins from cis to trans, is highly susceptible to HNE modification. Incubation of purified Pin1 with HNE followed by MALDI-TOF/TOF mass spectrometry resulted in detection of Michael adducts at the active site residues His-157 and Cys-113. Time and concentration dependencies indicate that Cys-113 is the primary site of HNE modification. Pin1 was adducted in MDA-MB-231 breast cancer cells treated with 8-alkynyl-HNE as judged by click chemistry conjugation with biotin followed by streptavidin-based pulldown and Western blotting with anti-Pin1 antibody. Furthermore, orbitrap MS data support the adduction of Cys-113 in the Pin1 active site upon HNE treatment of MDA-MB-231 cells. siRNA knockdown of Pin! in MDA-MB-231 cells partially protected the cells from HNE-induced toxicity. Recent studies indicate that Pin1 is an important molecular target for the chemopreventive effects of green tea polyphenols. The present study establishes that it is also a target for electrophilic modification by products of lipid peroxidation.
引用
收藏
页码:270 / 279
页数:10
相关论文
共 50 条
  • [41] The protein phosphatase 2A phosphatase activator is a novel peptidyl-prolyl cis/trans-isomerase
    Jordens, J
    Janssens, V
    Longin, S
    Stevens, I
    Martens, E
    Bultynck, G
    Engelborghs, Y
    Lescrinier, E
    Waelkens, E
    Goris, J
    Van Hoof, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (10) : 6349 - 6357
  • [42] Revealing the Disordered Inter-Domain Dynamics of Peptidyl-Prolyl Cis/Trans Isomerase Pin1 by Single Molecule FRET Measurements
    Kim, Sungho
    Lee, Seung Won
    Kim, Hajin
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 333A - 333A
  • [43] Inhibition of peptidyl-prolyl cis/trans isomerase Pin1 induces cell cycle arrest and apoptosis in vascular smooth muscle cells
    Lv, Lei
    Zhou, Zhaoxiong
    Huang, Xiaozhong
    Zhao, Yingping
    Zhang, Lan
    Shi, Yaxue
    Sun, Mingli
    Zhang, Jiwei
    APOPTOSIS, 2010, 15 (01) : 41 - 54
  • [44] Aryl indanyl ketones:: Efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pin1
    Daum, Sebastian
    Erdmann, Frank
    Fischer, Gunter
    de Lacroix, Boris Feaux
    Hessamian-Alinejad, Anahita
    Houben, Sabine
    Frank, Walter
    Braun, Manfred
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (44) : 7454 - 7458
  • [45] Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries
    Wildemann, D
    Erdmann, F
    Alvarez, BH
    Stoller, G
    Zhou, XZ
    Fanghänel, J
    Schutkowski, M
    Lu, KP
    Fischer, G
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (07) : 2147 - 2150
  • [46] THE THERAPEUTIC EFFECTS OF THE PEPTIDYL-PROLYL CIS/TRANS ISOMERASE PIN1 INHIBITOR JUGLONE ON ANIMAL-MODEL EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
    Ge, Z. Z.
    Wu, Y. B.
    Xue, Z. Y.
    Zhang, K.
    Zhang, R. X.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2021, 72 (02):
  • [47] Peptidyl Prolyl Cis/Trans Isomerase Pin1 Interacts with CRTC2 and Regulates Gluconeogenesis
    Nakatsu, Yusuke
    Sakoda, Hideyuki
    Fujishiro, Midori
    Kushiyama, Akifumi
    Kikuchi, Takako
    Nishimura, Fusanori
    Kamata, Hideaki
    Asano, Tomoichiro
    DIABETES, 2010, 59 : A410 - A410
  • [48] Preparation of Protein Transduction Domain-Fused Peptidyl Prolyl cis/trans Isomerase Pin1
    Ohashi, Tsubasa
    Teshima, Sumito
    Hidaka, Masafumi
    Uchida, Takafumi
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2010, 74 (10) : 2067 - 2070
  • [49] Molecular dynamics simulations of wild type and mutant of Pin1 peptidyl-prolyl isomerase
    Chang, Shan
    Kong, Ren
    Wang, Li-qin
    Shi, Hang
    Piao, Lian-hua
    MOLECULAR SIMULATION, 2016, 42 (15) : 1281 - 1291
  • [50] Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1
    Liu, WF
    Youn, HD
    Zhou, XZ
    Lu, KP
    Liu, JO
    FEBS LETTERS, 2001, 496 (2-3) : 105 - 108